NMC Update: New Prescribing Standards from 1 June 2025

BCAM fully supports the NMC’s decision to strengthen prescribing standards for non-surgical cosmetic procedures. From June, a face-to-face consultation will be required before prescribing POMs like botulinum toxin — a crucial step toward improving patient safety and professional accountability.

• A face-to-face consultation will be required before prescribing prescription-only medicines for non-surgical cosmetic procedures (e.g. botulinum toxin).
• Applies to nurse and midwife independent prescribers across the UK.
• This change supports safer, more accountable practice and aligns with other UK health regulators.
• NMC research identified: – A lack of public awareness that these treatments involve prescribed medicines
•  Concerns about unregulated environments and non-qualified practitioners
• While some stakeholders favoured video consultations, the emphasis is on clinical safety and professional oversight.
• Clinics and prescribers must review protocols to ensure compliance by the deadline.

These changes apply to nurse and midwife independent prescribers across the UK.

We believe this move is a positive and necessary shift for the future of aesthetic medicine. 

Full guidance now available via the NMC’s “Useful Information for Prescribers”.

View other News